CareDx to Participate in 42nd Annual Goldman Sachs Global Healthcare Conference
CareDx, a precision medicine company, announced its participation in the 42nd Annual Goldman Sachs Global Healthcare Conference on June 8, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CareDx, a precision medicine company, announced its participation in the 42nd Annual Goldman Sachs Global Healthcare Conference on June 8, 2021. The event will feature a management presentation scheduled for 1:40 p.m. Pacific time / 4:40 p.m. Eastern time. Investors can listen to the live webcast through CareDx’s investor relations page. CareDx specializes in high-value healthcare solutions for transplant patients and their caregivers.
Details
News Market Reaction – CDNA
The recorded move for CDNA in the trading session of this news was -0.01%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SOUTH SAN FRANCISCO, Calif., June 03, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced today the Company plans to participate in the 42nd Annual Goldman Sachs Global Healthcare Conference.
CareDx’s management will be participating in the Goldman Sachs Virtual Healthcare Conference on Tuesday, June 8, 2021 at 1:40 p.m Pacific time / 4:40 p.m. Eastern time. To listen to a live webcast, please visit the investor relations section of CareDx’s website at: investors.caredxinc.com.
About CareDx
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. For more information, please visit: www.CareDx.com.
CONTACTS:
CareDx, Inc.
Sasha King
Chief Marketing Officer
415-287-2393
sking@caredx.com
Investor Relations
Greg Chodaczek
347-610-7010
investor@caredx.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.